ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis

Michele B. Kaufman, PharmD, BCGP  |  January 6, 2020

In a phase 3 study, ixekizumab proved safe and effective for improving the signs and symptoms of non-radiographic axial spondyloarthritis (axSpA) in combination with conventional background medications, such as NSAIDs…

Filed under:Drug Updates Tagged with:2019 ACR/ARP Annual Meetingaxial spondyloarthritis (SpA)ixekizumabnon-radiographic axial spondyloarthritis

Coding Corner Questions: Rheumatology Word Search

From the College  |  December 18, 2019

Questions What type of drug is interchangeable with an FDA-approved biologic? What drug is used in conjunction with infliximab, unless the patient cannot tolerate it? What can be used as a key element in an evaluation and management (E/M) service, along with the history, exam and medical decision making? What drives the level of an…

Filed under:Billing/CodingFrom the College Tagged with:Evaluation and Managementinfliximab

Ankylosing Spondylitis & Uveitis: An Ophthalmologist’s Perspective

Jason Liebowitz, MD, FACR  |  December 18, 2019

It’s often said the eyes are the window to the soul, and in the case of ankylosing spondylitis and other spondylo­arthropathies, one can also say the eyes are the window to systemic disease. Although uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing SpondylitisAS Resource CenterHLA-B27opthamologistUveitis

Lessons from Master Clinicians: An Interview with Dr. Paul Plotz

Jason Liebowitz, MD, FACR  |  December 18, 2019

Rheumatologists who are outstanding clinicians, provide consistently exceptional care to patients and serve as role models for colleagues and trainees are in the spotlight in our Lessons from a Master Clinician series. Here, we offer insights from clinicians who have achieved a level of distinction in the field of rheumatology. Paul Plotz, MD, is scientist…

Filed under:Patient PerspectiveProfessional TopicsProfiles Tagged with:Dr. Paul PlotzLessons from Master CliniciansRole Models in Rheumatology

Hair dye being applied to a man’s beard.

Case Report: A 50-Year-Old Man Suffers Dye-Induced Arthritis

Hrudya Abraham, MD, Eric Warm, MD, FACP, & Avis Ware, MD  |  December 18, 2019

Hair dye products are commonly used by both men and women to enhance youth and beauty and to follow fashion trends. As reported in the medical literature, hair dyes and their ingredients are associated with allergic contact dermatitis. A possible association with joint inflammation has also been recognized. There is literature to support that para-phenylenediamine…

Filed under:Conditions Tagged with:case reportenvironmental factorpara-phenylenediamine (PPD)

Remote Use of the Multidimensional Health Assessment Questionnaire (MDHAQ)

Juan Schmukler, MD, & Theodore Pincus, MD  |  December 18, 2019

The patient medical history is far more prominent in clinical decisions for rheumatology than for many common chronic diseases in which a gold standard biomarker, such as blood pressure or serum glucose, is applicable to diagnosis and management of all individual patients.1 Components of a subjective patient history may be recorded as structured, quantitative, standard,…

Filed under:ConditionsTechnology Tagged with:case reportMultidimensional Health Assessment Questionnaire (MDHAQ)Routine Assessment of Patient Index Data (RAPID)

On Boulders & Other Projects

Philip Seo, MD, MHS  |  December 18, 2019

The year is drawing to a close, and I have not been forced to release a statement that I am leaving The Rheumatologist “to spend more time with my family.” Once again, improbably, I have made it to the finish line. Given that, now seems to be a good time to reflect, and to give…

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:American College of Rheumatology (ACR)

Depression in Ankylosing Spondylitis: Mastery Is Key

Lara C. Pullen, PhD  |  December 13, 2019

A recent study indicates that depression in patients with ankylosing spondylitis is a result of both contextual and disease-related factors. Researchers found a patient’s mastery—the perception they have control over things in their lives—plays a key role in the development of depression in this patient population…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing SpondylitisDepressionmastery

Make Rehab Fun: Virtual Reality & Therapeutic Gaming

Thomas R. Collins  |  December 12, 2019

Using virtual reality in rehabilitation can have benefits—as long as it is properly understood. In fact, some evidence suggests benefits from the judicious use of immersive virtual reality with patients with rheumatic diagnoses. People tend to have a lower perception of effort compared with actual exertion and lower reports of pain with longer time to exhaustion.

Filed under:Meeting ReportsTechnology Tagged with:2019 ACR/ARP Annual MeetingExercise/physical therapyoccpational therapy

Beyond Drugs: ACR/AF Guideline Update for Hand, Knee & Hip OA Emphasizes Exercise

Susan Bernstein  |  December 12, 2019

Guideline authors discussed therapeutic options for patients with hand, knee and hip OA in a session at the 2019 ACR/ARP Annual Meeting.

Filed under:Clinical Criteria/GuidelinesConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:2019 ACR/ARP Annual Meetinghand osteoarthritiship osteoarthritsknee osteoarthritisosteoarthritis (OA)

  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 247
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences